AMBUJACEM.NS Financials

Financials

Trends

* Timeframes marked with (Est.) are analyst estimates based on consensus data.

Details

Breakdown	2026	2025	Change %
Total Revenue	399.694.000.000	336.540.700.000	18.8%
Cost of Revenue	91.097.700.000	83.792.600.000	8.7%
Gross Profit	308.596.300.000	252.748.100.000	22.1%
	277.657.400.000	215.945.700.000	28.6%
Operating Income	30.938.900.000	36.802.400.000	15.9%
Pretax Income	32.987.700.000	61.036.700.000	46.0%
Net Income Common Stockholders	47.281.800.000	43.031.000.000	9.9%
	--	--	--
	--	--	--